Clinical Trial

CORONA in the Saarland

Study acronym: CORSAAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-04-06; most recent amendment 2025-05-21.
Trial Details
NCT Number NCT04837755
Lead Sponsor Universität des Saarlandes
Conditions Covid19
Enrollment 300 participants
Start Date 2020-03-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-25